CRIS Current Research Information System

CHIODO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.119
EU - Europa 5.608
AS - Asia 5.518
SA - Sud America 474
AF - Africa 373
OC - Oceania 5
Totale 18.097
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.084
CN - Cina 2.057
GB - Regno Unito 1.877
SG - Singapore 1.516
DE - Germania 792
UA - Ucraina 792
VN - Vietnam 790
SE - Svezia 579
IT - Italia 469
HK - Hong Kong 363
RU - Federazione Russa 347
BR - Brasile 342
IN - India 331
FR - Francia 247
JP - Giappone 198
IE - Irlanda 179
KR - Corea 168
ZA - Sudafrica 150
NL - Olanda 121
SC - Seychelles 75
CI - Costa d'Avorio 72
EE - Estonia 67
AR - Argentina 65
TG - Togo 54
FI - Finlandia 37
BG - Bulgaria 21
EC - Ecuador 20
CH - Svizzera 18
ID - Indonesia 18
GR - Grecia 15
MX - Messico 15
PY - Paraguay 15
CA - Canada 14
JO - Giordania 14
AT - Austria 12
CO - Colombia 12
IQ - Iraq 10
CL - Cile 9
PL - Polonia 9
IR - Iran 8
BD - Bangladesh 7
TR - Turchia 7
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
LB - Libano 5
NG - Nigeria 5
RO - Romania 5
PE - Perù 4
TN - Tunisia 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
KE - Kenya 3
LT - Lituania 3
BE - Belgio 2
DK - Danimarca 2
DZ - Algeria 2
ES - Italia 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
NP - Nepal 2
PK - Pakistan 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TL - Timor Orientale 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 18.097
Salva come PNG Salva come JPEG
Città #
Southend 1.684
Singapore 943
Hefei 650
Fairfield 642
Jacksonville 581
Ashburn 491
Chandler 385
Hong Kong 362
Wilmington 361
Santa Clara 350
Woodbridge 304
Princeton 303
Seattle 288
Dong Ket 285
Houston 278
Cambridge 246
Tokyo 191
Nanjing 185
Dublin 178
Boardman 170
Beijing 169
Seoul 168
Ann Arbor 163
Padova 160
Westminster 150
Berlin 128
Ho Chi Minh City 105
Los Angeles 101
Mülheim 89
Saint Petersburg 82
Jinan 79
Buffalo 73
Abidjan 72
Mahé 71
Hanoi 70
Milan 67
Shenyang 67
Lomé 54
Hebei 52
Medford 47
Nanchang 46
San Diego 45
Verona 43
Bengaluru 40
Changsha 38
Tianjin 37
Bologna 31
Hangzhou 31
Helsinki 31
New York 29
São Paulo 28
Guangzhou 26
Zhengzhou 26
Ningbo 25
Dallas 23
Dearborn 22
Jiaxing 22
Norwalk 22
The Dalles 22
Sofia 21
Shanghai 20
Rio de Janeiro 19
Kunming 18
Lanzhou 18
Olalla 17
Turin 17
Frankfurt am Main 16
Haikou 15
Amman 14
Bühl 14
Chicago 13
Fuzhou 13
Redondo Beach 13
Redwood City 13
London 11
Phoenix 11
Taizhou 11
Yubileyny 11
Des Moines 10
Düsseldorf 10
Falkenstein 10
Haiphong 10
Wuhan 10
Bern 9
Foshan 9
Guayaquil 9
Salvador 9
Xi'an 9
Brasília 8
Curitiba 8
Frankfurt Am Main 8
Belo Horizonte 7
Florence 7
Quito 7
San Francisco 7
Shenzhen 7
Shijiazhuang 7
Sorocaba 7
Taiyuan 7
Asunción 6
Totale 11.897
Salva come PNG Salva come JPEG
Nome #
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 233
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 211
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 194
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 194
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 193
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 180
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 179
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 177
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 174
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 161
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 159
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 158
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 157
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 156
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 156
Pancreotoxicity of propofol sedation during purulent meningitis. 155
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 154
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 151
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 151
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 151
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 150
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 149
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 149
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 149
Prevalence And Mutational Pattern Of Occult Hepatitis B Virus Isolated From Liver Tissue Of HIV Infected Patients 149
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 147
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 147
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 147
Neurosyphilis in a young adult: very early tertiary syphilis? 143
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 143
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 142
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 142
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 142
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 141
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 141
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 141
Legionnaires' disease associated with macular rash: two cases 141
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 141
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 140
Measles outbreak in the city of Bologna, December 2007 to May 2008 140
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 140
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 139
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 139
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 138
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 138
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 137
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 136
Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass 134
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 133
Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: a rare, but intriguing association. Two case reports and literature review 133
An extremely different dysmetabolic profile between the two available nonucleoside reverse transcriptase inhibitors: efavirenz and nevirapine. 132
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 132
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 132
Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention. 131
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 131
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 131
Hyperacute fulminant fungal peritonitis and ascites in a HIV-infected patient with HCV-related, compensated liver cirrhosis. A supportive role for prolonged nimesulide self-administration? 128
Concurrent naso-pharyngeal squamous cell carcinoma and lymphoproliferative disorder during HIV infection. Possible pathogenetic interactions among retroviral infection, Epstein-Barr virus infection, and inhalatory cocaine abuse 127
Multiple, severe lung infiltrates due to Mycobacterium avium-intracellulare in a patient with decompensated liver cirrhosis: spontaneous resolution after a two-year follow-up 127
The "Great Imitator". Syphilis as causative agent of isolated, concurrent acute hepatitis and meningitis 127
First-line efavirenz- versus lopinavir-ritonavir-based highly active antiretroviral therapy for naive patients 126
Acute reactivation of a severe pulmonary tuberculosis during associated interferon pegylate-ribavirin treatment carried out for a known chronic hepatitis C 126
Antiretroviral treatment and gynecomastia: which correlations? 124
Sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) to antimicrobial agents other than beta-lactams: profile and trend, 1998-2003 124
Comparison between switching therapy from protease inhibitors to an NNRTI and lipid-lowering therapy with pravastatin or bezafibratef for the management of HAART-related dyslipidemia 124
Bartonellosis: light and shadows in diagnostic and therapeutic issues 124
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis 124
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds 122
Changing epidemiology of hepatitis A in Italy 121
Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid - meropenem treatment 121
Changing epidemiology of acute hepatitis A and hepatitis B in Italy: further counselling and prophylactic measures are needed for male homo-bisexual subjects? 120
Disorders of glucose metabolism and insulin resistance in HIV-infected patients treated with protease inhibitors: considerations on frequency and clinical management, in a prospective, randomized study 119
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 119
Gynecomastia in a vertically-infected adolescent treated since birth 118
Severe pneumococcal meningitis heralding a deep hypogammaglobulinaemia related to common variable immunodeficiency, at the age of 27 years. 118
The role of the novel HIV fusion inhibitor enfuvirtide in multiresistant vertical AIDS treated since birth 117
Terapia antiretrovirale con inibitori nucleosidici della trascrittasi inversa ed epatotossicità nei pazienti HIV positivi 116
Extra-western European citizens in the setting of infectious diseases: a rapidly evolving trend in northern Italy. 116
A case-control study of HIV-associated pancreatic abnormalities during HAART era. Focus on emerging risk factors and specific management. 115
Dyslipidaemia during HIV disease: a comparison of efavirenz- and nevirapine-based regimens 114
AIDS e patologie tumorali multiple come condizioni emergenti in epoca di terapia antiretrovirale altamente attiva (HAART) 114
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. 113
Una rara complicanza infettiva in corso di trapianto ortotopico di fegato: gestione della peritonite tubercolare 112
Secondary syphilis presenting with acute severe hepatic involvement in a patient with undiagnosed HIV disease 112
How to evaluate rise in serum lactate levels of HIV-infected patients undergoing antiretroviral therapy? Data from a prospective, case-control survey. 111
Increased patients' age: a mounting epidemiological, clinical, and therapeutic problem in the HIV disease scenario 111
Antibiotic therapy for infective endocarditis in childhood 110
Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogue. 110
Quantitative-qualitative burden of admissions of Extra-Western Europe citizens in a reference Infectious Disease unit in Northern Italy, 1999-2004 109
The two non-nucleoside HIV reverse transcriptase inhibitors:significantly different dysmetabolic profile between efavirenz and nevirapine 109
Symptomatic, primary Cytomegalovirus (CMV) infection in otherwise healthy adults. Increased incidence, or increased resort to improved laboratory facilities? 109
Nucleoside analogue transcriptase inhibitors and liver toxicity among patients treated for hiv disease 109
Syphilis does not seem to involve virological and immunological course of concurrent HIV disease 109
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART 109
HIV-associated polymyositis. A rare complication prompted by antiretroviral-related immune reconstitution 108
Slowly progressing and indolent pulmonary mucormycosis (zigomycosis) in a patient with an underlying multiple sclerosis, managed without immunosuppressive therapy 108
Tick-borne infections 108
Limited access to hospitalization in an Italian infectious disease ward 108
Increasing reports of gynecomastia among HIV-infected patients treated with highly active antiretroviral therapy. Epidemiological and clinical correlates, and suggestions for pathogenetic 107
Trattamento in carcere di pazienti difficili portatori di infezione HCV con interferone pegilato associato a ribavirina. Ruolo del counselling nel ridurre il drop-out 106
Totale 13.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.365
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.181 0 0 0 0 0 124 18 125 110 156 113 535
2021/20222.485 287 111 205 266 200 146 42 158 67 185 437 381
2022/20231.972 277 343 128 234 101 116 69 82 336 40 187 59
2023/2024367 38 73 35 28 23 67 18 20 8 31 13 13
2024/20252.382 43 519 229 155 578 88 115 25 5 152 12 461
2025/20263.614 299 907 818 705 699 186 0 0 0 0 0 0
Totale 18.282